Van Veen and colleagues found that the low-producer CCL5 allele rs2107538-G was associated with reduced risk of severe axonal loss, whereas the high-producer CCL5 allele rs2107538-A was associated with a worse clinical course of multiple sclerosis [58]. This evidence concerns the gene CCL5 and multiple sclerosis.